COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT01332968
Brief Title: A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)

First Submitted : April 8, 2011
First Submitted that Met QC Criteria : April 8, 2011
First Posted : April 11, 2011 (Estimate)

Results First Submitted : February 3, 2017
Results First Submitted that Met QC Criteria : May 5, 2017
Results First Posted : June 7, 2017

Last Update Submitted that Met QC Criteria : December 31, 2019
Last Update Posted : January 3, 2020